IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Quarter Est. Return
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$284M
AUM Growth
+$26.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
71
New
Increased
Reduced
Closed

Top Buys

1
+$12.6M
2
+$5.68M
3
+$4.84M
4
STML
Stemline Therapeutics, Inc.
STML
+$4.84M
5
EXEL icon
Exelixis
EXEL
+$4.74M

Top Sells

1
+$5.75M
2
+$5.23M
3
+$2.95M
4
ADMS
Adamas Pharmaceuticals
ADMS
+$2.54M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$2.36M

Sector Composition

1 Healthcare 91.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$3.36M 1.18%
1,505,804
+533,882
27
$3.14M 1.11%
322,436
28
$3.08M 1.08%
57,500
29
$3.03M 1.07%
185,000
-88,000
30
$3M 1.06%
108,000
31
$2.87M 1.01%
37,000
-29,000
32
$2.59M 0.91%
51,500
33
$2.53M 0.89%
115,500
+29,000
34
$2.48M 0.87%
16,506
+13,297
35
$2.3M 0.81%
+382,838
36
$2.29M 0.81%
+25,000
37
$2.28M 0.81%
50,000
-13,000
38
$2.2M 0.77%
204,538
+130,000
39
$1.88M 0.66%
17,000
40
$1.75M 0.62%
77,000
+52,000
41
$1.71M 0.6%
+17,000
42
$1.71M 0.6%
68,391
43
$1.5M 0.53%
27,000
-94,000
44
$1.49M 0.52%
1,256
45
$1.33M 0.47%
+145,000
46
$1.27M 0.45%
+9,600
47
$1.23M 0.43%
+4,333
48
$1.19M 0.42%
+12,000
49
$1.17M 0.41%
24,000
50
$1.15M 0.41%
+375
1
2
3